Tradeup Acquisition Corp (ESLA) - News Archive

Estrella Immunopharma, Inc. (NASDAQ: ESLA), a cutting-edge clinical-stage biopharmaceutical company, is making significant strides in the fight against cancer. The company has announced a breakthrough in its STARLIGHT-1...

Estrella Immunopharma Advances Cancer Therapy in STARLIGHT-1 Trial: First Dose Cohort Completed and Higher Dose Cohort Approved In a significant stride within the field of biopharmaceuticals, Estrella Immunopharma, Inc....

Evaluating Estrella Immunopharma s Potential Amid Industry Challenges In an ever-evolving biopharmaceutical landscape, Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW), a clinical-stage company pioneering CD19 and CD22...

In a remarkable leap forward in cancer treatment, Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) has announced a significant milestone in its STARLIGHT-1 Phase I/II clinical trial. The company, known for its innovati...

In a groundbreaking advancement in the realm of cancer and autoimmune disease therapies, Estrella Immunopharma, Inc. (NASDAQ: ESLA, ESLAW) has reported a significant milestone in its clinical experimentation. The biopha...